(Q34532766)

English

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

scientific article published on April 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation (English)

1 reference

Europe PubMed Central

2 August 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

Anthony H. Goldstone

13

object named as

A H Goldstone

1 reference

Europe PubMed Central

2 August 2017

8

object named as

D. Blaise

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

author name string

European Bone Marrow Transplantation (EBMT) Lymphoma Registry

14

1 reference

Europe PubMed Central

2 August 2017

A. J. Peniket

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

M. C. Ruiz de Elvira

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

G. Taghipour

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

C. Cordonnier

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

E. Gluckman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

T. de Witte

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

G. Santini

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

H. Greinix

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

A. Ferrant

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

J. Cornelissen

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

N. Schmitz

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12692607

23 December 2023

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

2 August 2017

full work available at URL

https://www.nature.com/articles/1703891

1 reference

10.1038/SJ.BMT.1703891

https://api.crossref.org/works/10.1038/SJ.BMT.1703891

23 December 2023

https://www.nature.com/articles/1703891.pdf

Portable Document Format

1 reference

10.1038/SJ.BMT.1703891

https://api.crossref.org/works/10.1038/SJ.BMT.1703891

23 December 2023

Bone Marrow Transplantation

1 reference

Europe PubMed Central

2 August 2017

31

1 reference

Europe PubMed Central

2 August 2017

667-678

1 reference

Europe PubMed Central

2 August 2017

8

1 reference

Europe PubMed Central

2 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703891

0 references

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

21 January 2018

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy followed by bone marrow transplantation for relapsed follicular non-Hodgkin's lymphoma. Dutch HOVON Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703891

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703891

1 reference

Europe PubMed Central

2 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34532766&oldid=2037085949"